Nuveen’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $207K | Sell |
|
|||||
|
2023
Q4 | $462K | Sell |
|
|||||
|
2023
Q3 | $3.15M | Buy |
|
|||||
|
2023
Q2 | $2.09M | Buy |
|
|||||
|
2023
Q1 | $1.53M | Sell |
|
|||||
|
2022
Q4 | $3.17M | Sell |
|
|||||
|
2022
Q3 | $3.48M | Sell |
|
|||||
|
2022
Q2 | $3.5M | Sell |
|
|||||
|
2022
Q1 | $5.12M | Buy |
|
|||||
|
2021
Q4 | $4.39M | Buy |
|
|||||
|
2021
Q3 | $4.94M | Buy |
|
|||||
|
2021
Q2 | $3.23M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $115K | Buy |
|
|||||
|
2019
Q4 | $191K | Sell |
|
|||||
|
2019
Q3 | $125K | Sell |
|
|||||
|
2019
Q2 | $280K | Buy |
|